Manufacturers Life Insurance Company, The Immunome Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Immunome Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 165,491 shares of IMNM stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165,491
Previous 166,928
0.86%
Holding current value
$1.87 Million
Previous $2.02 Million
19.81%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMNM
# of Institutions
121Shares Held
47.1MCall Options Held
322KPut Options Held
1.91M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.76MShares$64.9 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$55.1 Million4.67% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$43.7 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$42.4 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$39.3 Million0.03% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $137M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...